Valid and specific biomarkers can have a major impact on the diagnosis of a variety of disorders and diseases, allowing early diagnosis which may influence the patient’s prognosis. The usefulness of biomarkers in cancer diagnostics for screening and monitoring treatment response is an area of particular interest for the development of in vitro diagnostic tests. In addition to cancer screening, biomarkers have proven particularly useful for diagnosing acute coronary events because responding with appropriate medical treatment relies on a rapid result and electrocardiogram changes may be absent or nonspecific. OnSite Rapid Tests detect well-characterized biomarkers including fecal occult blood (FOB), prostate-specific antigen (PSA) and Troponin I.
Showing all 10 results